RY

131.78

-1.17%↓

TD

73.57

-0.39%↓

BMO

113.72

-0.71%↓

BNS

54.56

-0.96%↓

CM

73.07

-0.46%↓

RY

131.78

-1.17%↓

TD

73.57

-0.39%↓

BMO

113.72

-0.71%↓

BNS

54.56

-0.96%↓

CM

73.07

-0.46%↓

RY

131.78

-1.17%↓

TD

73.57

-0.39%↓

BMO

113.72

-0.71%↓

BNS

54.56

-0.96%↓

CM

73.07

-0.46%↓

RY

131.78

-1.17%↓

TD

73.57

-0.39%↓

BMO

113.72

-0.71%↓

BNS

54.56

-0.96%↓

CM

73.07

-0.46%↓

RY

131.78

-1.17%↓

TD

73.57

-0.39%↓

BMO

113.72

-0.71%↓

BNS

54.56

-0.96%↓

CM

73.07

-0.46%↓

Search

MetLife Inc.

Gesloten

SectorFinanciën

77.66 -0.83

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

77.19

Max

78.32

Belangrijke statistieken

By Trading Economics

Inkomsten

-326M

945M

Verkoop

-92M

18B

K/W

Sectorgemiddelde

12.938

25.072

EPS

1.96

Dividendrendement

2.82

Winstmarge

5.168

Werknemers

45,000

EBITDA

-1.3B

1.6B

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+22.07% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.82%

3.86%

Volgende Winsten

6 aug 2025

Volgende dividenddatum

9 sep 2025

Volgende Ex Dividend datum

5 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-5.8B

54B

Vorige openingsprijs

78.49

Vorige sluitingsprijs

77.66

Nieuwssentiment

By Acuity

50%

50%

201 / 536 Rangschikking in Finance

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

MetLife Inc. Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

27 mrt 2025, 13:30 UTC

Winsten

Small Businesses Are Stalling, New Report Shows. It Could Be a Warning for the Economy. -- Barrons.com

20 mrt 2025, 05:00 UTC

Winsten

Qualcomm and 6 More Stocks for Today's Uncertain Market -- Barrons.com

31 jul 2024, 20:16 UTC

Winsten

MetLife 2Q Book Value Per Shr, Excluding AOCI Other Than FCTA, Was $53.12 >MET

31 jul 2024, 20:15 UTC

Winsten

MetLife 2Q Net Investment Income $5.21B >MET

31 jul 2024, 20:15 UTC

Winsten

MetLife 2Q Operating Revenue $18.68B >MET

31 jul 2024, 20:15 UTC

Winsten

MetLife 2Q Rev $17.82B >MET

31 jul 2024, 20:15 UTC

Winsten

MetLife 2Q Book Value Per Shr $33.30 >MET

Peer Vergelijking

Prijswijziging

MetLife Inc. Prognose

Koersdoel

By TipRanks

22.07% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 95.67 USD  22.07%

Hoogste 110 USD

Laagste 90 USD

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor MetLife Inc. - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

13 ratings

11

Buy

2

Hold

0

Sell

Technische score

By Trading Central

75.86 / 77.81Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Bearish Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

201 / 536 Rangschikking in Financiën

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over MetLife Inc.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was incorporated in 1999 and is based in New York, New York.